Recapitulating Pancreatic Tumor Microenvironment through Synergistic Use of Patient Organoids and Organ‐on‐a‐Chip Vasculature
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Tumor progression relies on the interaction between neoplastic epithelial cells and their surrounding stromal partners. This cell cross‐talk affects stromal development, and ultimately the heterogeneity impacts drug efficacy. To mimic this evolving paradigm, 3D vascularized pancreatic adenocarcinoma tissue is microengineered in a tri‐culture system composed of patient‐derived pancreatic organoids, human fibroblasts, and endothelial cells on a perfusable platform, situated in a 96‐well plate. Through synergistic engineering, the benefits of cellular fidelity of patient tumor organoids are combined with the flow control of an organ‐on‐a‐chip platform. Validation of this platform includes demonstrating the growth of pancreatic tumor organoids by monitoring the change in metabolic activity of the tissue. Investigation of the tumor microenvironment highlights the role of fibroblasts in symbiosis with patient organoids, resulting in a six‐fold increase of collagen deposition and corresponding increase in tissue stiffness in comparison to fibroblast free controls. The value of a perfusable vascular network is evident in drug screening, as perfusing gemcitabine into stiffened matrix does not show the dose‐dependent effects on decrease in tumor viability as those under static conditions. These findings demonstrate the importance of a dynamic synergistic relationship between patient cells with stromal fibroblasts, in a 3D perfused vascular network, to accurately recapitulate a dynamic tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“they can emulate human (patho)physiology in a more human-like environment49,51,55–57.”
From Human disease models in drug development (2023) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“This organoid-on-a-chip model may serve as a valuable tool for studying the interactions between cancer cells and the TME, providing a platform for personalized medicine in PDAC.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lai et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“A recent study introduced a perfusable, 3D organoid-on-a-chip model to recapitulate the PDAC TME (Lai et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lai et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Research works printed but not linked: 2
- Netti P. A., 2000, Cancer Res., 60, 2497
- Conze D., 2001, Cancer Res., 61, 8851
Cited by
Items 101–142 of 142
Organoids in translation: a bench-to-bedside framework for pancreatic cancer precision medicine
Malik, D. A., Schmieder, E., Genova, G., Gaskins, J., & Martin, R. C. G. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07596-8 · Cited by 10
Dinić, J., Stojanov, S. J., Dragoj, M., Grozdanić, M., Podolski-Renić, A., & Pešić, M. (2024) · Life · doi:10.3390/life14091142 · Cited by 11
The third dimension of tumor microenvironment—The importance of tumor stroma in 3D cancer models
Plavá, J., Čeháková, M., Kuniaková, M., Trnkova, L., Cihova, M., Boháč, M., & Danišovič, Ľ. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231198050 · Cited by 9
Wu, Z., Zeng, B., Seah, D. H., Ng, I. Z. R., Ding, R. H., Zhang, T., Kalaichelvan, M., You, R., & Fong, E. L. S. (2025) · Advanced Materials · doi:10.1002/adma.202512252 · Cited by 5
Global Literature Analysis of Tumor Organoid and Tumor-on-Chip Research
Shoji, J., Davis, R. P., Mummery, C. L., & Krauss, S. J. K. (2025) · Cancers · doi:10.3390/cancers17010108 · Cited by 5
Petrauskas, V., Damaseviciute, R., & Gulla, A. (2025) · Medicina · doi:10.3390/medicina61040623 · Cited by 5
A biomechanical view of epigenetic tumor regulation
Zhao, B., & Lv, Y. (2023) · Journal of Biological Physics · doi:10.1007/s10867-023-09633-3 · Cited by 4
Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens
Wang, M., Gao, C., Huang, X. S., Wang, M., Zhang, S., Gao, X., Zhong, C., & Li, L. (2025) · Cancers · doi:10.3390/cancers17040692 · Cited by 3
Bioengineering 3D Pancreatic Cancer Models with Fibrotic Stroma for In Vitro Cancer Modeling
Lan, X., Chen, K., & Wei, X. (2025) · Micromachines · doi:10.3390/mi16101140 · Cited by 4
Organoid-Immune Co-Cultures: A Next-Generation approach to disease modeling
Najafi, F., Zoghi, N. A., Khalili, H., Najafi, N., Yazdi, M. H., & Sisakht, M. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11450-5 · Cited by 4
Deconstructing cancer in 3D: models, mechanisms, and personalized solutions
Huang, Z., Duan, X., Ji, J., Cai, Q., Jin, P., Yu, B., & (48506), J. Z. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02704-8 · Cited by 5
The Microenvironment of Solid Tumors: Components and Current Challenges of Tumor-on-a-Chip Models
Souza, I. D. F., Vieira, J. P. D. J., Bonifácio, E., Freitas, B. A. D. A., & Torres, L. A. G. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0088 · Cited by 5
Advancements in Organ‐on‐a‐Chip Systems: Materials, Characterization, and Applications
Gunasekaran, B. M., Srinivasan, S., Ezhilan, M., Rajagopal, V., & Nesakumar, N. (2024) · ChemistrySelect · doi:10.1002/slct.202403611 · Cited by 5
Human Cardiac Organoids: Quantification and Qualification in Cardiovascular Studies
Liu, Y., Abraham, S., & Xu, H. (2024) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2024.100017 · Cited by 2
Manach, D. L., Kowsari‐Esfahan, R., Reszczyńska, E., Nghe, P., & Nees, M. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503566 · Cited by 2
Kpeglo, D., Haddrick, M., Knowles, M. A., Evans, S. D., & Peyman, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-30612-2 · Cited by 2
Zhou, S., Shan, F., Zhang, Y., Cao, Y., Cen, J., Kaji, N., & Liu, S. (2026) · Lab on a Chip · doi:10.1039/d5lc00857c · Cited by 2
Li, Y., Cao, Z., Xu, Y., Li, C., Ye, S., Wu, X., Wang, Z., Chen, H., Liu, H., Hu, X., et al. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-026-01244-x · Cited by 4
Suku, M., Murphy, J. F., Corbezzolo, S., Biggs, M. J. P., Forte, G., Turnbull, I. C., Costa, K. D., Forrester, L. M., & Monaghan, M. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.04.626684 · Cited by 4
Vascularized tumor organoids enable immunotherapy testing in tumor-remodeled stromaPreprint
Wimmer, R., Krese, R., Henniger, L., Niu, S., Lagarde, N., Keller, T., Clausen, I., Köchel, F., Ferrara, C., Waldhauer, I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.23.701300 · Cited by 3
A Microfluidic Vascular Chip for in Vitro Studying Responses of Anti-cancer Drugs
Gao, M., Xin, S., Jiang, T., & Wei, Z. (2023) · International Conference on Biomedical Engineering and Applications (ICBEA) · doi:10.1109/icbea58866.2023.00027 · Cited by 1
Tumor-on-chip platforms for transport phenotyping: decoding CAF-driven barriers to drug delivery
Manach, D. L., Senez, V., & Nees, M. (2026) · Lab on a Chip · doi:10.1039/d5lc01131k · Cited by 2
Dai, Z., Fu, G., Du, Y., Xie, Y., ZHU, J., Tao, X., Luo, Q., Chu, X., & Lei, Z. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102873 · Cited by 3
Enabling Technologies in Vascular Biology: Microphysiological Systems, Organoids, and Beyond
Gholizadeh, H., & Benam, K. H. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.323054 · Cited by 1
Decoding drug resistance and apoptosis in biliary tract cancers using 3D tumor models
Gill, G. S., Sahoo, O. S., Nayek, A., Sarkar, S. K., Kurdia, K. C., Bhardwaj, N., Das, C. J., Galodha, S., Goyal, G., Karmakar, S., et al. (2026) · Frontiers in Cell Death · doi:10.3389/fceld.2026.1819303 · Cited by 1
Vascularization of organoids in microfluidic chips
Chowdary, P., Yadav, D. N., Pogu, S. V., & Rengan, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00016-4 · Cited by 1
3D in vitro modeling of the exocrine pancreatic unit using tomographic volumetric bioprintingPreprint
Sgarminato, V., Madrid-Wolff, J. A., Boniface, A., Ciardelli, G., Tonda‐Turo, C., & Moser, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.23.525142 · Cited by 1
Human organs-on-a-chip for cancer modeling
Hegde, M., Girisa, S., & Harsha, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00005-x
"Harnessing the power of organoids for improved outcomes in pancreatic cancer"
Kirola, L., Kedia, S., & Mohanty, S. (2025) · Pancreatology · doi:10.1016/j.pan.2025.02.008
Tumor-on-a-Chip: From Biomimetic Tumor-Immune Microenvironments to Therapeutic Insights
Çetin, Y. (2025) · Biochemistry · doi:10.5772/intechopen.1012047
Regenerative Medicine and Endocrinology: Advanced Cell Therapies for Diabetes
Ghezelayagh, Z., Tahamtani, Y., Valizadeh, M., & Aghayan, H. R. (2025) · Springer eBooks · doi:10.1007/978-981-95-2286-6_4
Beutel, A. K., & Kleger, A. (2025) · Die Onkologie · doi:10.1007/s00761-025-01844-8
Qin, X., Zhao, Y., Wu, Y., Efelis, A., Paul, R., Islam, K., Marquez, C. S., Liu, Y., & Liu, Y. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01908
Pancreatic organoids and organoid-on-a-chip platforms: from disease modeling to precision therapy
Lin, M., Ma, W., Ma, T., He, Y., Shi, H., Ge, N., Guo, J., Xie, Y., Sun, S., & Yang, F. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08489-0
Sun, C., Wu, G., Wu, D., Du, Q., Lu, Q. W., Hu, W., Wang, J., xie, A., Yao, Z., Xia, M., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.06.041 · Cited by 1
Guo, D., Hu, X., Adhikari, S., Patri, S. K., Storozhuk, L., & Thanh, N. T. K. (2026) · Nanoscale Horizons · doi:10.1039/d6nh00070c
Patient-derived organoids in pancreatic cancer: Advances and applications in precision oncology
Lee, H. S., & Koo, B. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i3.46
Biofabrication for spatial control of multiscale biological crosstalk in tissue models
Yoon, G., Kim, J., & Jang, J. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-026-00102-9
Organoid Coculture Models for Cancer Research and Immunotherapy
Yang, Z., Yang, H., Guangxin, L., Liu, G., Chen, Z., Tian, W., Huang, M., Liu, X., Zhao, Y., & Chen, D. (2026) · Med Research · doi:10.1002/mdr2.70087
Li, H., ZHANG, Y., Ma, C., FU, L., Han, S., Li, L., Zhong, C., & Tian, Y. (2026) · Translational research · doi:10.1016/j.trsl.2026.08.010
On‐Demand Generation of Patient‐Derived Organoids for Precision Oncology: Progress and Prospects
Guo, Z., Yang, S., Shen, K., Liu, Y., & Xu, X. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71817
Organ-on-a-chip using induced pluripotent stem cells
Ludlow, M., Childs, M., Chakravarty, A., Truong, B., Abdelrahman, S., Jozani, K. A., & Zhang, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00007-8
Metadata
- Authors
- Lai, B. F. L., Lu, R. X. Z., Hu, Y., Davenport Huyer, L., Dou, W., Wang, E. Y., Radulovich, N., Tsao, M. S., Sun, Y., & Radisic, M.
- Affiliations
- University of Toronto (CA)
- Institute of Biomaterials and Biomedical Engineering University of Toronto Toronto Ontario Canada
- University Health Network (CA)
- Corresponding author
- Radisic, Milica
- ORCID
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-06-08
- Volume
- 30
- Issue
- 48
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- PMC
- PMC7939064
- OpenAlex
- W3035635204
- Cited by
- 142
- References
- 91
- Citations by year
- 2026: 22 · 2025: 29 · 2024: 32 · 2023: 32 · 2022: 17 · 2021: 9 · 2020: 1
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Advanced Functional Materials (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (MOP‐126027, MOP‐137107, MOP‐142382, FDN‐167274)
- Natural Sciences and Engineering Research Council of Canada (RGPIN 326982‐10)
- National Science Foundation (2R01 HL076485)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- pancreatic ductal adenocarcinoma, tumor microenvironment, organ-on-a-chip, perfusable vascular networks, stromal fibroblasts, collagen deposition, tissue stiffness, 3D tissue engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.